Helix Selects DNA Genotek’s Oragene® Collection Device and GenoFIND Services
News Dec 03, 2016
OraSure Technologies Inc has announced that Helix has selected the Oragene®●Dx device to provide reliable self-collection of DNA samples to be used in a genetic information discovery service offered by Helix for consumers. OraSure’s wholly-owned subsidiary, DNA Genotek, will supply the Oragene®●Dx device and will also provide kit fulfillment and logistics services for Helix through its GenoFIND offering. Helix provides a secure and affordable means for consumers to access data and information about their DNA, through uniquely personalized applications created by Helix partners.
The Oragene®●Dx collector will be used to collect saliva samples from consumers and those samples will be sequenced in Helix’s lab. Customers will then be able to access DNA-powered insights in products and experiences created by Helix partners—including well-known clinical and consumer brands—in the areas of health, fitness, genealogy, family planning, lifestyle, and nutrition.
“Reliable and easy-to-use sample collection is a key part of our offering. The ability to collect a high quality DNA sample for next generation sequencing is critical to ensuring accurate results for our customers,” said Dr. James Lu, Co-founder & Senior Vice President of Applied Genomics at Helix. “DNA Genotek is a leader in its field, and we are excited to work with them to bring customers an efficient experience right from the start.”
"We are pleased that Helix has selected both our saliva collection kits and GenoFIND services to support their offering. Their vision and approach to empowering every person to improve their life through DNA is truly innovative and we are excited that Oragene®●Dx will be an integral part of the Helix customer experience,” said Brian Smith, Senior Vice President and General Manager at DNA Genotek.
Oragene®●Dx is an all-in-one system for the easy self-collection and stabilization of DNA from saliva. The device allows for ambient temperature storage and transportation and provides a liquid sample to enable high throughput automated processing in a laboratory. Oragene®●Dx is the first and only DNA collection and stabilization device to receive 510(k) clearance in the USA. GenoFIND offers a complete suite of genomics and microbiome services from study design through bioinformatics analysis and interpretation. Oragene®●Dx is FDA 510(k) cleared for in vitro diagnostic use with the eSensor® Warfarin Sensitivity Saliva Test.
Source: Story from OraSure Technologies Inc. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.